Introduction
The pathology of Parkinson's disease (PD) is characterized by a loss of dopaminergic neurons in the substantia nigra and the formation of intracellular inclusions, known as Lewy bodies [1, 2] . One of the key proteins in the pathogenesis of PD is α-synuclein, which is encoded by the SNCA gene. SNCA duplications and triplications, as well as N-terminal A30P, E46K, and A53T missense mutations, have been linked to autosomal dominantly inherited PD [3] [4] [5] [6] [7] . In vivo studies in transgenic mice and flies overexpressing the wildtype and mutant Snca further demonstrated the pathogenic effect of α-synuclein in neurons [8, 9] . In contrast to the well-defined pathogenic effects of α-synuclein, its biological function is far less understood. It is thought that α-synuclein might be responsible for regulating the size of the presynaptic vesicle pool in primary hippocampal neurons [10] .
α-Synuclein is part of a family of proteins that includes β-and γ-synuclein [11] . At the amino acid level, γ-synuclein shares a 60% similarity with α-synuclein [12] . Both proteins are expressed in the thalamus, substantia nigra, caudate nucleus, amygdala, and the hippocampus [13] . γ-Synuclein is abundant in the spinal cord and sensory ganglia [14] . Interestingly, it is more widely distributed within the neuronal cytoplasm than α-and β-synuclein, being present throughout cell bodies and axons [14] . The presence of synucleins has also been detected in other cell types: α-synuclein was found in platelets [15] , whereas γ-synuclein was present in the epidermis [16] and in metastatic breast cancer tissue [17] , respectively. γ-Synuclein is also known as persyn and BCSG-1 (breast cancer-specific gene 1) [18] and is significantly up-regulated in more than 70% of late stage breast and more than 85% of ovarian carcinomas [19] . γ-Synuclein has multiple actions. It stimulates the liganddependent breast cancer cell and cell proliferations and up-regulates matrix metalloproteases, which are enzymes implicated in tumorgenesis and neurodegeneration [20, 21] . SNCG contains similar N-terminal and core domains as SNCA that cause nuclear exclusions. However, SNCG lacks the C-terminal domain of SNCA that supports its transport into the nuclear compartment [22] suggesting that the two synucleins might have different roles in the nucleus.
To define the biological functions of α-and γ-synuclein in vivo, knock-out mice have been generated. Inactivation of the Snca gene in mice by homologous recombination does not lead to a severe neurological phenotype [23] . SNCA −/− mice are viable, fertile, and do not display any gross pathological abnormalities. Dopaminergic neurons and nerve terminals are normally possessed and the central nervous system of SNCA −/− mice appears morphologically intact [23] . Nevertheless, they display a reduction in total striatal dopamine levels, as well as an attenuated locomotor response to amphetamine. Similar to SNCA −/− mice, absence of γ-synuclein in mice does not lead to any obvious phenotypical changes [24] . SNCG −/− null mutant mice are also viable, fertile, and do not display any gross pathological abnormalities. The number of neurons was not changed, and sensory reflex thresholds were also intact in SNCG −/− mice. A relatively small but statistically significant reduction in the number of tyrosine hydroxylase (Th)-positive neurons has been found in the substantia nigra pars compacta (SNpc) of adult SNCG −/− mice [25] . This reduction in the number of Th-positive neurons was also seen in SNCA
) double knock-out mice [25] . It was shown that dopaminergic neurons of the SNpc of SNCA
, and SNCA_G knock-out mice are resistant to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity [25] [26] [27] .
Except for expression analysis of the synuclein genes, there are basically no studies on the transcriptional dysregulation in SNCA −/− , SNCG −/− , and SNCA_G knock-out mice. In SNCA −/− mice, the expression levels for β-and γ-synuclein mRNA and protein appeared normal indicating that the absence of α-synuclein has not been compensated by other synuclein family members [23] . Likewise, the lack of γ-synuclein RNA and protein in SNCG −/− null mutant mice was not accompanied by compensatory increases of α-or β-synuclein mRNA levels [27, 28] . Considering these results, we initially hypothesized that α-synuclein and γ-synuclein participate in different pathways. To confirm this hypothesis, we performed transcriptome analysis of brain tissue of SNCA
, and SNCA_G knock-out mice and investigated whether or not altered expression pathways do overlap in the respective models.
Materials and methods

Animals
A colony of α-synuclein mutant mice on C57BL/6 background was established from well-described mice [23] . SNCA −/− and SNCG −/− mice were bred to produce double heterozygous and subsequently double γ-synuclein/ α-synuclein null mutant mice (SNCA_G −/− ), respectively [24, 25] . All mice had been maintained on an ad libitum diet with a 12-h dark to 12-h light cycle. Brains of three male 3-month-old SNCA −/− , SNCG
−/−
, and SNCA_G −/− mice as well as of C57BL/6-wildtype mice were dissected, snap-frozen, and kept at −80°C.
RNA preparation for Microarray analysis
Isolation of RNA from whole mouse brain was performed using RNAeasy® Kit (Qiagen, Germany) according to the manufacturer's recommendations. The quality of isolated RNA was controlled by Lab-on-Chip-System Bioanalyser 2100 (Agilent). Double-stranded cDNA was synthesized from the total RNA of each brain tissue using a Superscript choice kit (Invitrogen) with a T7-(dT) 24 primer incorporating a T7 RNA polymerase promoter (Metabion 
Pathway analysis
A total of 548 genes, defined by the criteria's described above, were used for the pathway analysis with the Ingenuity Pathway Analysis software 3.1 (Ingenuity Systems). The identified genes were mapped to genetic networks available in the Ingenuity database and were then ranked by score. The score is defined by the probability that a collection of genes equal to or greater than the number in the respective network could be achieved by chance alone. In this context a value of 3 indicates that there is a 1/1,000 chance that the focus genes are in a network because of random chance. Therefore, scores of 3 or higher have a 99.9% confidence of not being generated by random chance alone.
RNA isolation and cDNA preparation for q-RT-PCR
The cortex, cerebellum, midbrain, and brainstem of four different mice genotypes (WT, SNCA
, and SNCA_G −/− ) were dissected. The total RNA of two replicates was isolated using the RNeasy Mini Kit (Qiagen) including a DNase digest on the column with RNase-Free DNase Set (Qiagen). The RNA quality was controlled by Lab-on-Chip-System Bioanalyser 2100 (Agilent), and the concentration was determined using a BioPhotometer (Eppendorf). A total RNA of 0.5 μg was employed for the cDNA synthesis, which was performed with the QuantiTect Reverse Transcription Kit (Qiagen). The negative control (RT−) consists of a sample without quantiscript reverse transcriptase to exclude genomic DNA contamination of the sample. A 1:20 cDNA dilution was used in the quantitative real time polymerase chain reaction (q-RT-PCR).
Quantitative real time PCR
The q-RT-PCR was executed with LightCycler® 480 SYBR Green I Master (Roche) in the LightCycler®480 system (Roche). Primers (listed in Table 1 ) with an average length of 80-160 bp, spanning an exon-exon boundary, were designed using the Primer3 Software (http://frodo.wi.mit. edu/cgi-bin/primer3/primer3_www.cgi). The q-RT-PCR reaction (volume, 10 μl) contained 5 μM of each primer, 5 μl LightCycler® 480 SYBR Green I Master, and 1 μl of the 1:20 diluted cDNA. The quantitative PCR conditions were 95°C for 10 min followed by 45 cycles of 95°C for 15 s, 58°C for 10 s, and 72°C for 20 s. The acquisition was performed after the 72°C step of each cycle. Melting curves were generated at the end of the run. Standard curves of each amplified gene were created to obtain the PCR efficiency. Pyruvate dehydrogenase B (PDHB), succinate dehydrogenase A, and hydroxymethylbilane synthase were analyzed as reference (housekeeping) genes. PDHB was determined as the most adequate housekeeping gene using the GeNorm tool of the qBase software version 1.3.3. and applied for normalization. The Cp values of the reference gene and the target genes were detected by the LightCycler 480 software release 1.2.0.0625 applying the second derivative maximum method. Relative expression levels of all genes were calculated using the REST-384© (version 2) [30] .
Results
We compared whole transcriptome RNA expression profiles of total brain tissue of SNCA Fig. 1) , respectively. For many of the physiological pathways such as dopamine receptor signaling (down-regulated), cellular development, nervous system function, and cell death (upregulated), we found groups of genes that were similarly altered in SNCA −/− and SNCG −/− mice (Fig. 2) . On the other hand, other gene groups such as TGF-β signaling and apoptosis pathway genes were significantly up-regulated in the SNCA −/− mice but down-regulated in SNCG −/− mice (Fig. 2) . The Ingenuity software delivered 29 networks in SNCA −/− mice but only one including SNCA (Fig. 3a) .
Four of ten direct interacting proteins are up-regulated and one is down-regulated. Th and 14-3-3-zeta are direct interactors of Snca and have between 1.5 and 2.5 times higher expression levels than in wildtype mice. Investigating the expression profile of SNCG
, we received also 29 altered networks. Sncg has only one known differentially regulated direct interactor, which is G protein-coupled receptor kinase 5 (Grk5; down-regulated, Fig. 3b) . The other direct interactor of Grk5 in this network that is differentially regulated is Snca (down-regulated). Besides Grk5, Mapk1 is down-regulated and Th is up-regulated in SNCG −/− mice as well as 14-3-3-zeta, all similar to the changes seen in SNCA −/− mice.
A complete list of all differentially regulated genes in SNCA
, and SNCA_G −/− mice can be received from the authors. In the following, we will discuss selected genes according to their tentative assignment to groups of genes with a specific function.
Transcription pathways altered in α-and γ-synuclein single knock-out mice
Applying Ingenuity software we found one pathway that overlaps between SNCA −/− mice and SNCG −/− mice strongly: the Mapk1 pathway. In this pathway, 12 genes are up-regulated, and eight genes are down-regulated (Fig. 3a,b) . This implies that α-and γ-synuclein have some common functions despite their rather weak similarity of 60% at the amino acid level [15] . In contrast, other pathways for instance with the core transcript Tp53 were only altered in the SNCG −/− mice but not affected in SNCA −/− mice (Fig. 3c) suggesting also different functions of α-and γ-synuclein. Indeed, if both proteins would have entirely complementary functions, one might expect a more pronounced phenotype of the double knock-out mice and also more severe alterations of the regulatory pathways compared to single knock-out mice.
In SNCA −/− mice, we found numerous genes up-or down-regulated that are known to be involved in development and function of the nervous system such as Th (upregulated), glutamate receptor 1 (Gria1), Atm, Casp3, and Syt4 (all down-regulated). Some of these genes also contribute to cell death and apoptosis (Atm, Casp3, Cd59, Mapk1 [all down-regulated], and FosB [up-regulated]). Furthermore, several genes encode proteins in vesicle function or transport such as myocilin [31] , synaptotagmin IV [32] , and ataxia teleangiectasia mutated (Atm, [33] ).
In SNCG −/− mice, Snca was also down-regulated, which could possibly explain the overlap of genes of the Mapk1 pathway that were differentially regulated in the SNCA −/− mice. In none of the models, expression of Sncb, the third member of the synuclein family, was significantly changed. Most interestingly, Hap1, an interactor of the huntingtin protein, was also up-regulated in SNCG −/− mice adding to recent findings of tight interactions of disease pathways in PD and Huntington's disease. Similarly to SNCA −/− mice, where Gria1 was down-regulated, we found Gria2, the gene encoding the ionotropic α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor 2, downregulated in SNCG −/− mice. Other genes involved in cell death and apoptosis, such as Cd59, Cebpd, Fos, and JunB, were down-regulated as well.
Altered transcriptional pathways in α-/γ-synuclein double knock-out mice
We were interested how the transcriptional networks of the brain were changed in SNCA_G −/− double knock-out mice in comparison to the SNCA −/− or SNCG −/− single knockout mice. This analysis is interesting, as α-and γ-synuclein belong to the same protein family, but a direct interaction or involvement in the same pathways of both proteins has not been demonstrated yet. Studying the networks, we came to the following conclusions: (1) The level of expression of differentially regulated genes in the double knock-out mice compared to the single knock-out mice as measured by the respective SLRs, was not potentiated (Table 2) indicating that these proteins have no additive effects, (2) some of the proteins such as myocilin, kinesin family member 5B, Atm (all down-regulated in SNCA −/− mice), and guanine nucleotide binding protein beta 1 (up-regulated in SNCA −/− mice) were not differentially regulated in double knock-out mice, and (3) no regulatory pathway was altered in the double knock-out mice that was not already affected in the single knock-out mice which might explain that-as single SNCA −/− mice and SNCG −/− mice-double knockout mice are perfectly viable. In SNCA_G −/− double-knock-out mice, we found no network connecting Snca and Sncg; each of them was integrated in its own network.
q-RT-PCR validation in different brain areas
To validate the microarray data, we selected six differentially regulated genes and analyzed their expression in the cerebellum, cortex, midbrain, and brainstem ( Fig. 4a-e) . The first gene of interest was Snca, which was knocked out in all brain areas of SNCA −/− and SNCA_G −/− mice and down-regulated in all brain areas of SNCG −/− mice (Fig. 4a) . These data are in agreement with the microarray analysis. The Sncg gene was down-regulated in the SNCG
and SNCA_G −/− mice in all investigated brain areas as expected from the microarray data (Fig. 4b) . In the cortex and midbrain of SNCA −/− mice, the Sncg gene was upregulated like in the microarray analysis, whereas it was down-regulated in the cerebellum and not differentially regulated in the brainstem (Fig. 4b) . The up-regulation of Th in all mouse models found by microarray analysis has also been confirmed by q-RT-PCR analyses studying the midbrain of these mouse lines. These latter analyses showed an extreme up-regulation of Th in the cortex of SNCA −/− mice, whereas in all other brain areas the Th gene was down- Fig. 2 Regulated pathways in the knock-out models. Selection of differentially regulated pathways in SNCA −/− , SNCG −/− , and SNCA_G −/− mice implicate their functions in PD, TGF-β, dopamine, and glutamate signaling and in apoptosis and ER stress regulated (Fig. 4c) . In SNCA −/− mice, the Atm gene was down-regulated in all brain areas but was not found to be differentially regulated in the whole brain by microarray analysis of SNCG −/− and SNCA_G −/− mice (Fig. 4d) . All 
Mapk8 was the only gene investigated for which we did not confirm the microarray data by q-RT-PCR (data not shown).
Discussion
This is the first study that investigates the consequences of a total loss of function of α-synuclein, γ-synuclein, and of combined α-/γ-synuclein deficiency on expression networks in mouse brain. We found as well overlapping but also differing altered expression pathways in the two knock-out mouse models indicating partially overlapping but also individual functions of the two proteins. Sixty five genes were differentially regulated in the same direction in all three models, such as Snca, Mapk1, Sp1, Syt4, Th, and 14-3-3-zeta. These proteins fit into one pathway that is implicated in cellular growth and proliferation indicating that α-and γ-synuclein are involved in neuronal growth (Fig. 3a) . A key protein in this pathway that was up-regulated in both knock-out models (SLR in SNCA −/− =1.281, and in SNCG −/− =1.139) is 14-3-3. 14-3-3 proteins have been implicated in many neurodegenerative diseases as key molecules in neurotransmitter synthesis, transcriptional control, apoptosis, and regulators of protein kinases [34] . In particular, for PD, several molecular studies underline the involvement of 14-3-3 proteins in the pathogenesis. Initial studies suggest that 14-3-3 proteins bind α-synuclein Table 1 ) [36] . Furthermore, 14-3-3 inhibits parkin activity, which is abolished by several autosomal recessive juvenile PDcausing mutations [37] . We and others have shown that 14-3-3 proteins are components of the Lewy bodies [35] and although SNCA −/− mice do not develop these intracellular protein aggregates, our expression data support close functional interaction of α-synuclein and 14-3-3 proteins. This is further supported by analyzing SNCA_B −/− double knock-out mice in which a mild reduction in 14-3-3zeta and a slight increase in 14-3-3ɛ has been found at the protein level [38] . Our data, however, are not directly comparable to the ones of Chandra et al. [38] , as RNA and protein levels are not always directly correlated. Furthermore, there are age-and strain-dependent differences in the expression of genes. Whereas we used 3-month-old mice on a C57BL/ 6 background, 2-month-old mice were used in the former study, and the genetic background has not been mentioned. Unfortunately, Chandra et al. [38] did not study protein changes of the SNCA −/− single knock-out mice, which would have allowed a more direct comparison of the data.
It is assumed that α-synuclein and 14-3-3 regulate dopamine homeostasis through negative modulation of dopamine transporter activity [39, 40] and by regulation of dopamine biosynthesis [41] . Both proteins bind to Th [41, 42] , the ratelimiting enzyme in dopamine biosynthesis. Whereas the dopamine transporter was not differentially regulated, we found Th to be up-regulated, in both SNCA −/− and SNCG −/− mice. We confirmed the upregulation of Th by q-RT-PCR and found an increase in particular in the midbrain in all models. In SNCA −/− mice, a striking but consistent increase has been found in the cortex (Fig. 4) . A compensatory upregulation of Th has also been observed in the retina of SNCA −/− mice [43] .
SNCA inhibits the activity of Th by decreasing its phosphorylation, whereas interaction of 14-3-3 proteins with phosphorylated Th increased its activity [44] . One of the kinases phosphorylating Th is Mapk1 [45] , which has already been implicated in PD [46, 47] . Mapk1 RNA is decreased in SNCA −/− with a SLR of −3.016 and in SNCG −/− mice with a SLR of −1.847, respectively. Close [48] . In different cell lines, it was shown that the suppression of Mapk phosphorylation increases with higher levels of Snca [47, 49] . Mitogen-activated kinases mediate the transduction of external stimuli typically via receptor tyrosine kinase or G protein-coupled receptor activation [50] . Interestingly, Grk5 protein has been found as a component of the Lewy bodies and phosphorylates α-synuclein at position Ser-129 [51, 52] .
Although not changed at the transcriptional level in SNCA −/− mice, we found Grk5 to be down-regulated (SLR=−0.909) in SNCG −/− mice.
Other differentially expressed genes found in both knock-out models have also been implicated in synuclein function. One of these proteins is myocilin, which is an interactor of γ-synuclein. In cultured cells, γ-synuclein upregulates myocilin expression [53] suggesting that downregulation of γ-synuclein might cause similar effects for myocilin as well. However, as γ-synuclein is not a transcription factor per se, these regulatory pathways are only indirectly linked. Surprisingly, myocilin was significantly down-regulated in SNCA −/− mice (SLR=−2.16; Table 2 ) but not in SNCG −/− mice. However, it is too simple to assume that a reduction of one protein would lead to an up-or down-regulation of its direct interacting partners. Expression levels of other partners of α-synuclein, as synphilin-1 for instance, are not effected either. As long as the transcription factors regulating synuclein expression have not been defined yet, a straight comparison of complex pathways cannot be done easily. For SNCA −/− mice, our mRNA data indirectly support previous findings at the protein level that β-synuclein and γ-synuclein remain unchanged [23, 27] . In SNCA_B −/− double knock-out mice [38] , however, γ-synuclein was increased by 50%. It will be interesting to study these double knock-out mice at the mRNA level as well to correlate transcriptome data with the existing protein data. Ninkina et al. [24] found no compensatory increases of α-synuclein or β-synuclein in SNCG −/− mice. In contrast, in our microarray analysis, we did observe a reduced expression of α-synuclein in SNCG −/− mice. This might be due to different ages of the studied mice. On the other hand, expression of β-synuclein, which is a direct interactor of α-synuclein (Fig. 3b) [54, 55] and indirectly interacts with γ-synuclein (Fig. 3b ) [51] , is not differentially regulated (Fig. 3b) .
The down-regulation of the gene encoding the AMPA receptor Gria1 in SNCA −/− mice and of Gria2 in SNCG −/− mice is an interesting novel finding and might bring these models to the attention of behavioral scientist. Gria1 and Gria2 knock-out mice have been generated and display deficits in conditioned rewards [56, 57] and hippocampusdependent spatial working memory tasks [58] , suggesting that these receptors are important for synaptic plasticity. Although robust N-methyl-D -aspartate (NMDA)-dependent long-term potentiation has been observed in SNCA −/− mice [23] , detailed analysis of AMPA receptors are lacking, and in SNCG −/− mice, such experiments need still to be done.
Behavioral scientists have now models in hand to study reduced AMPA receptor glutamate receptors in addition to the complete knock-out mice. The definition of subtle phenotypes in the SNCA −/− mice becomes even more important, as deficiency of synaptotagmin IV leads to memory and motor deficits [59] and of Atm to a selective loss of dopaminergic nigrostriatal neurons in the respective knock-out mice [60, 61] . Although a clear motor phenotype and degeneration of dopaminergic neurons have not been observed for SNCA −/− mice, an attenuation of dopamine- The entire list of differentially regulated genes of all mice can be received from the authors dependent locomotor response to amphetamine has been shown [23] . As α-synuclein, Atm [33] , and synaptotagmin IV [62] bind to cytoplasmic vesicles suggesting that several gene products contribute to the subtle phenotype in the SNCA −/− mice.
The data derived from the whole genome microarray analysis of the SNCA −/− and SNCG −/− mice also allow a comparison to toxic mouse models of PD. Basically, there is only a minor overlap of the altered gene signatures between the knock-outs and MPTP and 6-hydroxydopamine induced models [63] [64] [65] or to MPP + -treated dopaminergic cell lines [66, 67] . However, these toxic models cause a clear degeneration of dopaminergic neurons with a rapid pathology and are therefore not directly comparable to the knock out models. Interestingly, both SNCA −/− and SNCG −/− mice are resistant to MPTP toxicity of dopaminergic neurons in the substantia nigra [25] . For the toxic models, it will be interesting to learn whether the altered expression pathways reflect more closely the situation in the transgenic PD models and to study if resistance to toxicity is purely due to Snca and/or Sncg deficiency or rather due to a complex network of genes protecting neuronal cells.
